5 July 2023
Cancers | Highly Cited Papers and Hot Topic Special Issues on Breast Cancer Research


We are delighted to share some highly cited papers on breast cancer research that were published in the journal Cancers (ISSN: 2072-6694) in 2021 and 2022. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will be of interest to you.

“Breast Tumour Classification Using Ultrasound Elastography with Machine Learning: A Systematic Scoping Review”
by Ye-Jiao Mao, Hyo-Jung Lim, Ming Ni, Wai-Hin Yan, Duo Wai-Chi Wong and James Chung-Wai Cheung
Cancers 2022, 14(2), 367; https://doi.org/10.3390/cancers14020367
Available online: https://www.mdpi.com/2072-6694/14/2/367

“Exosomes as Emerging Drug Delivery and Diagnostic Modality for Breast Cancer: Recent Advances in Isolation and Application”
by Dulla Naveen Kumar, Aiswarya Chaudhuri, Farrukh Aqil, Deepa Dehari, Radha Munagala, Sanjay Singh, Ramesh C. Gupta and Ashish Kumar Agrawal
Cancers 2022, 14(6), 1435; https://doi.org/10.3390/cancers14061435
Available online: https://www.mdpi.com/2072-6694/14/6/1435

“Role of ctDNA in Breast Cancer”
by Marta Sant, Adrià Bernat-Peguera, Eudald Felip and Mireia Margelí
Cancers 2022, 14(2), 310; https://doi.org/10.3390/cancers14020310
Available online: https://www.mdpi.com/2072-6694/14/2/310

“Triple Negative Breast Cancer: Updates on Classification and Treatment in 2021”
by Maroun Bou Zerdan, Tala Ghorayeb, Fares Saliba, Sabine Allam, Morgan Bou Zerdan, Marita Yaghi, Nadeem Bilani, Rola Jaafar and Zeina Nahleh
Cancers 2022, 14(5), 1253; https://doi.org/10.3390/cancers14051253
Available online: https://www.mdpi.com/2072-6694/14/5/1253

“HER2-Low Breast Cancer: Molecular Characteristics and Prognosis”
by Elisa Agostinetto, Mattia Rediti, Danai Fimereli, Véronique Debien, Martine Piccart, Philippe Aftimos, Christos Sotiriou and Evandro de Azambuja
Cancers 2021, 13(11), 2824; https://doi.org/10.3390/cancers13112824
Available online: https://www.mdpi.com/2072-6694/13/11/2824

“Molecular Targets of Triple-Negative Breast Cancer: Where Do We Stand?”
by Emma E. Newton, Lauren E. Mueller, Scout M. Treadwell, Cindy A. Morris and Heather L. Machado
Cancers 2022, 14(3), 482; https://doi.org/10.3390/cancers14030482
Available online: https://www.mdpi.com/2072-6694/14/3/482

Comprehensive Genomic Profiling for Metastatic Breast Cancer: Current Status and Future Perspectives

Edited by: Dr. Hiroshi Tada and Dr. Hiroko Masuda
Submission deadline: 30 September 2023

Single Cell RNA Sequencing in Breast Cancer

Edited by: Dr. Yu-Chih Chen
Submission deadline: 1 November 2023

 

Molecular Mechanisms in Breast Cancer Therapy and Resistance

Edited by: Dr. Lei Duan
Submission deadline: 30 November 2023

BRCA-Associated Breast Cancer

Edited by: Dr. Matilde Pensabene, Dr. Carmine De Angelis and Prof. Dr. Matteo Lambertini
Submission deadline: 15 December 2023

We hope this announcement will provide useful information for this field.

Back to TopTop